Cargando…

Reply to: “COVID-19-associated liver injury (COVALI): role of hepatologists”

Detalles Bibliográficos
Autores principales:	Li, Dongxiao, Ding, Xiangming, Tian, Dean, Xia, Limin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Singapore 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8274257/ https://www.ncbi.nlm.nih.gov/pubmed/34251568 http://dx.doi.org/10.1007/s00535-021-01807-x

Ejemplares similares

COVID-19-associated liver injury (COVALI): role of hepatologists
por: Sumida, Yoshio, et al.
Publicado: (2021)

COVID-19-associated liver injury: from bedside to bench
por: Li, Dongxiao, et al.
Publicado: (2021)

The liver in times of COVID-19: What hepatologists should know
por: Ridruejo, Ezequiel, et al.
Publicado: (2020)

Nonalcoholic Fatty Liver Disease in Diabetics: The Role of Hepatologist
por: Khandelwal, Reshu, et al.
Publicado: (2022)

Gastroenterologists, Hepatologists, COVID-19 and the Use of Acetaminophen
por: Rodríguez-Morales, Alfonso J., et al.
Publicado: (2020)

What hepatologists need to know about COVID-19?
por: Yapali, Suna
Publicado: (2020)

Effect of COVID-19 on Pre-existing Liver disease: What Hepatologist Should Know?
por: Sharma, Praveen, et al.
Publicado: (2021)

Reply to: Comments on “Association of liver abnormalities with in-hospital mortality in patients with COVID-19”
por: Ding, Ze-yang, et al.
Publicado: (2021)

Reply to: “Liver tests abnormalities in COVID-19: trick or treat?”
por: Cai, Qingxian, et al.
Publicado: (2020)

Reply to: “Clinical characteristics of COVID-19 patients with abnormal liver tests”
por: Cai, Qingxian, et al.
Publicado: (2020)

Reply to: “Association of chronic liver disease with the prognosis of COVID-19 patients”
por: Mallet, Vincent, et al.
Publicado: (2022)

Non-alcoholic fatty liver disease in diabetes: When to refer to the hepatologist?
por: Khandelwal, Reshu, et al.
Publicado: (2021)

In Reply: Hormones and COVID-19
por: Park, Myung S., et al.
Publicado: (2023)

Reply to: “NAFLD is a predictor of liver injury in COVID-19 hospitalized patients but not of mortality, disease severity on the presentation or progression – The debate continues”
por: Ji, Dong, et al.
Publicado: (2021)

Care Pattern for Fontan-Associated Liver Disease by Academic Pediatric Hepatologists in Canada
por: Kehar, Mohit, et al.
Publicado: (2022)

Reply to “The outbreak of COVID-19: An overview”
por: Wu, Yi-Chi, et al.
Publicado: (2020)

Reply: CPET for Long COVID-19
por: Mancini, Donna M., et al.
Publicado: (2022)

Reply to the syndemic of “COVID-19 and tuberculosis”
por: Patil, Rajashri A., et al.
Publicado: (2023)

Reply to: “Age and comorbidity are central to the risk of death from COVID-19 in liver transplant recipients”
por: Rodríguez-Perálvarez, Manuel, et al.
Publicado: (2021)

Reply to: A key role for vitamin D binding protein in COVID-19?
por: Arab-Ahmadi, Mehran, et al.
Publicado: (2021)

Plasma hemoglobin in COVID-19: authors’ reply
por: Lancman, Guido, et al.
Publicado: (2020)

In reply—The “Perfect Cytokine Storm” of COVID-19
por: Vijayvargiya, Prakhar, et al.
Publicado: (2020)

Reply to “Novaferon, treatment in COVID-19 patients”
por: Zheng, Fang, et al.
Publicado: (2021)

Reply to Comment on “Osteoporosis in the Age of COVID-19”
por: Girgis, C. M., et al.
Publicado: (2021)

Reply to “Pulmonary toxicity by oxygen and COVID-19”()
por: Belenguer-Muncharaz, A., et al.
Publicado: (2022)

Reply To: Response to COVID-19 by the surgical community
por: Chapman, Robert
Publicado: (2020)

Type and dose of heparin in Covid‐19: Reply
por: Thachil, Jecko, et al.
Publicado: (2020)

Liver injury in COVID-19 – The culprit may not be COVID-19!
por: Singh, Aditya, et al.
Publicado: (2021)

Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: Has the Time Come for Cardiologists to Be Hepatologists?
por: Ahmed, Mohamed H., et al.
Publicado: (2012)

Factors influencing the participation of gastroenterologists and hepatologists in clinical research
por: Dev, Anouk T, et al.
Publicado: (2008)

Advancing health equity: The Association of Black Gastroenterologists and Hepatologists
por: White, Pascale M., et al.
Publicado: (2021)

Liver Injury in COVID-19: Caution and Management
por: Cao, Jiasheng, et al.
Publicado: (2020)

'Post-COVID-19 chronic symptoms' – Author's reply
por: Davido, Benjamin, et al.
Publicado: (2021)

‘Treatment of COVID-19 with convalescent plasma’ – Author’s reply
por: Wooding, Denise J., et al.
Publicado: (2021)

Reply to the letter concerning Kawasaki disease and Covid-19
por: Loomba, Rohit S., et al.
Publicado: (2020)

Reply to “Consensus document on tracheotomy in patients with COVID-19”()
por: Martín Delgado, M.C., et al.
Publicado: (2021)

Reply to: Trajectories of vital signs in patients with Covid-19
por: Redfern, Oliver C., et al.
Publicado: (2021)

Reply to Consensus document on tracheotomy in patients with COVID 19()
por: Pérez Acosta, G., et al.
Publicado: (2021)

In reply—COVID-19: Precision Medicine and Vascular Endothelium
por: Cresci, Sharon, et al.
Publicado: (2021)

Reply to “Impact of COVID-19 on the mental health of radiologists”
por: Demirjian, Natalie L., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3lj793tn72pepgkca54efp1j5l